Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
ONE•Beauty Space Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
BROOKLYN, NY, UNITED STATES, August 4, 2026 /EINPresswire.com/ -- ONE•Beauty Space is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Sofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business Highlights
GlobeNewswire, Inc.
Second quarter revenue of $30M, +43% year-over-year growth; IFRS gross margin of 76.5% Second quarter usage fee revenue of $13.9M, 52.2% year-over-year growth First half revenue of $54.4M, +44% year-over-year growth; IFRS gross margin of 75.8%...
Israel Innovation Authority Launches NIS 100 Million National Quantum Computing R&D Infrastructure
EIN Presswire
JERUSALEM, ISRAEL, July 20, 2026 /EINPresswire.com/ -- The Israel Innovation Authority has launched a new call for proposals to establish a national research and development infrastructure that will provide Israeli industry and academia with...
Israel Invests NIS 6 Million to Advance the Next Generation of Blue-Tech Energy Technologies
EIN Presswire
New Funding Program Aims to Support Breakthrough Ocean-Based Renewable Energy Technologies, from Wave Energy to AI-Powered Offshore Energy Systems JERUSALEM, ISRAEL, July 20, 2026 /EINPresswire.com/ -- The Israel Innovation Authority and the...
Nexalin Technology Announces Reverse Stock Split
GlobeNewswire, Inc.
HOUSTON, TX, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), announces that its board of directors has approved a 1-for-30 reverse stock split of the Company’s common stock, to ensure...
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
GlobeNewswire, Inc.
TEL AVIV, Israel, July 28, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus", “Nasus Pharma” or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced...
Sheba Medical Center Collaborates with OpenAI on Its First International Healthcare Deployment
EIN Presswire
A Major Step in the Hospital’s AI Transformation, Collaboration Will Provide Clinicians with OpenAI's Most Advanced Clinical Reasoning Platform RAMAT GAN, ISRAEL, July 28, 2026 /EINPresswire.com/ -- Sheba Medical Center announced today a...
Assured Raises $19M Series A Led by Insight Partners to Automate Healthcare Provider Operations with AI Agents
GlobeNewswire, Inc.
NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- This funding accelerates Assured’s mission to replace manual healthcare provider operations with AI agents, so providers get onboarded faster and patients receive care sooner.
Merit Medical Reports Second Quarter 2026 Results And Updates Full-Year 2026 Guidance
GlobeNewswire, Inc.
Financial Highlights† Reported revenue of $418.8 million, up 10% Constant currency revenue* and constant currency revenue, organic* up 9% and up 9%, respectively GAAP operating margin of 14.4%, compared to 12.3% in prior year period Non-GAAP...
Israel Launches First Regulatory Sandbox for Artificial Intelligence in Healthcare
EIN Presswire
Three Israeli HealthTech Companies Selected to Advance Autonomous AI Systems for Pregnancy Care, Heart Failure Management, and Home Ultrasound JERUSALEM, ISRAEL, July 13, 2026 /EINPresswire.com/ -- The Israel Innovation Authority and the...
UroGen Pharma to Report Second Quarter 2026 Financial Results on Wednesday, August 5th, 2026
GlobeNewswire, Inc.
PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will...
Israel Innovation Authority Invests Approx. NIS 70 Million in National Infrastructure for AI Models Based on Bio Data
EIN Presswire
New Israel BioToken Factory Initiative (IBFI) Brings Together NVIDIA, Teva, Sheba Medical Center, Startups and Universities to Develop Next Generation of Bio AI JERUSALEM, ISRAEL, July 12, 2026 /EINPresswire.com/ -- The Israel Innovation...
Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial
GlobeNewswire, Inc.
Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (“Clearmind” or “Company”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments for Alcohol Use Disorder...
C2A Security Takes Top Position in Frost Radar™: Automotive Product Security and Compliance, 2026
EIN Presswire
Takes Top Position on the Innovation, Growth Index and Visionary Leaders Quadrant in Frost Radar™: Automotive Product Security and Compliance Solutions, 2026 JERUSALEM, ISRAEL, August 25, 2026 /EINPresswire.com/ -- C2A Security, the only context...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. (“Agios” or the “Company”) (NASDAQ: AGIO). Such investors are advised to contact Danielle Peyton at...
123rd Medical Group and Kentucky Guard Airmen honored for national excellence
DVIDS - Georgia
The Kentucky Air National Guard’s 123rd Medical Group has been named Air National Guard Medical Unit of the Year, and two of its officers have been recognized for individual excellence in the 2025 Air National Guard Medical Service Awards.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ionis Pharmaceuticals, Inc. - IONS
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ionis Pharmaceuticals, Inc. (“Ionis” or the “Company”) (NASDAQ: IONS). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alignment Healthcare, Inc. - ALHC
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Alignment Healthcare, Inc. (“Alignment” or the “Company”) (NASDAQ: ALHC). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA
GlobeNewswire, Inc.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or...
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.